Heparin component for the treatment of neutrophil...

Details Heparin component for the treatment of neutrophil... Heparin component for the treatment of neutrophil...

A - Human Necessities

61

K

A61K 38/57 (2006.01) A61K 9/12 (2006.01) A61K 9/72 (2006.01) A61K 31/727 (2006.01) A61K 31/725 (1990.01)

Patent

CA 2105528

ABSTRACT OF THE DISCLOSURE Lung inflammation, in particular neutrophil elastase- mediated inflammation, can be treated by administration of a composition comprising an effective amount of a component selected from the group consisting of heparins and heparin-like molecules, the composition being adapted to present the active component to the lung of the patient. The composition is of value to patients suffering from cystic fibrosis.

Affiliated with

Also associated with

Rating

Heparin component for the treatment of neutrophil... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heparin component for the treatment of neutrophil..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heparin component for the treatment of neutrophil... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1621002